Results 221 to 230 of about 830,673 (331)
Invasive lobular carcinoma of the breast with multifocal gastrointestinal, ovarian, and peritoneal metastases: a case report. [PDF]
Karkeabadi N +4 more
europepmc +1 more source
Bevacizumab added to systemic chemotherapy remains a cornerstone of metastatic colorectal cancer treatment, but its effectiveness is variable. Tumors can bypass the VEGF blockade by activating other pro‐angiogenic pathways, hampering the identification of predictive biomarkers.
Büsra Akay Hacan +9 more
wiley +1 more source
Rewiring transcriptional plasticity: the case for dual YAP1 and TAZ targeting in gastric cancer peritoneal metastases. [PDF]
Kumar R.
europepmc +1 more source
This review presents a framework for selecting Claudin 18.2 (CLDN18.2)‐directed treatment modalities in pancreatic ductal adenocarcinoma according to tumour antigen coverage and spatial distribution. Representative assessment at baseline and reassessment after progression can guide treatment adaptation over time.
Ruyu Tan +5 more
wiley +1 more source
Tailoring HIPEC with Patient-Derived Organoids in Colorectal Peritoneal Metastases: Results from the First Stage of the Prospective Phase II OrganoHIPEC Clinical Trial (Clinicaltrials.gov NCT06057298). [PDF]
Baratti D +9 more
europepmc +1 more source
ABSTRACT Clear cell sarcoma of soft tissue (CCSST) with malignant effusion is a rare yet clinically aggressive appearance, which may pose a diagnostic pitfall with its overlapping cytomorphologic features with metastatic melanoma and carcinoma.
William H. Wu +2 more
wiley +1 more source
Current Challenges and Future Directions in the Multimodal Management of Gastric Cancer with Peritoneal Metastases. [PDF]
Cossu A, Puccetti F, Rosati R, Elmore U.
europepmc +1 more source
The detection of tumor‐infiltrating lymphocytes (TILs) is a positive prognostic factor in ovarian cancer. Moreover, TILs are significantly boosted by immunotherapy, though ovarian cancer patients have seen limited benefit from immune therapies. This study investigated the safety and feasibility of TIL therapy combined with PD‐1 and LAG‐3 inhibitors in ...
Tine J. Monberg +9 more
wiley +1 more source
ABSTRACT The standard for assessing and recording the extent of the tumour, a necessity for most malignancies, is the Tumour Node Metastases (TNM) classification. The Union for International Cancer Control (UICC) TNM committee has defined this since the early 1950s.
James D. Brierley +8 more
wiley +1 more source
Grade 1 Hepatic Neuroendocrine Tumor with Peritoneal Metastases: Case Report - Diagnostic Reasoning and Management Challenges. [PDF]
Tsai TL, Guo JW, Lin CL, Lien HH.
europepmc +1 more source

